 |
Recombinant human gelsolin |
|---|---|
| Trade Name | |
| Orphan Indication | Acute and chronic respiratory symptoms of bronchiectasis |
| USA Market Approval | USA |
| USA Designation Date | 1995-03-06 00:00:00 |
| Sponsor | BioAgeis, Therapeutics, Inc.;6 East Cove Lane;Morristown, New Jersey, 07960 |
